FDA MedWatch Safety AlertsOriginal article
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
RegulatoryDexmedetomidine HCl in 0.9% Sodium Chloride InjectionNegative
AI Analysis
Summary
Par Health voluntarily recalled two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection to the hospital level due to the presence of particulate matter identified as cellulose or stopper material.
Outcome Details
Voluntary nationwide recall of two lots due to presence of particulate matter (cellulose or stopper material)
Importance:3/10
Sentiment:
-0.80
product recallquality issueparticulate matterinjectionvoluntary recall
Read the original article
Published by FDA MedWatch Safety Alerts on September 21, 2026 4:00 AM